Miraculins Announces Debt Extension from Secured Lenders
16 Mai 2014 - 10:30PM
Marketwired
Miraculins Announces Debt Extension from Secured Lenders
WINNIPEG, MANITOBA--(Marketwired - May 16, 2014) - Miraculins
Inc. (TSX-VENTURE:MOM) ("Miraculins" or the "Company"), a medical
diagnostic company focused on acquiring, developing and
commercializing diagnostic and risk assessment technologies for
unmet clinical needs, announces that it has entered into amending
agreements to extend its CDN$1,000,000 nonconvertible secured loan
with Gretchen Ross (the "2011 Lender") that was originally
announced on October 13, 2011 and previously extended on December
23, 2013, and to extend its CDN$611,334 nonconvertible secured loan
from a third party lender (the "2013 Lender") that was originally
announced on December 23, 2013.
The loans have been extended and will now mature on December 31,
2015. The loans will continue to bear interest at 12% per annum and
the interest will accrue until December 31, 2015.
As consideration for the extension of the loans, the Company
will, subject to regulatory approval, issue 500,000 common shares
to the 2011 Lender and 500,000 common shares to the 2013
Lender.
All of the shares to be issued to the 2011 Lender and the 2013
Lender will be subject to resale restrictions for a period of four
months from the date of issuance under applicable securities
legislation.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Miraculins Inc.Christopher J. MoreauPresident &
CEO204-477-7599204-453-1546info@miraculins.comwww.miraculins.com
Miraculins Inc. (TSXV:MOM)
Historical Stock Chart
Von Aug 2024 bis Sep 2024
Miraculins Inc. (TSXV:MOM)
Historical Stock Chart
Von Sep 2023 bis Sep 2024
Echtzeit-Nachrichten über (TSX Venture Börse): 0 Nachrichtenartikel
Weitere Miraculins Inc. News-Artikel